E-nitiateBio

Hangzhou, China · Founded 2020 · Privately Held (backing)

Developer of new drugs designed for autoimmune diseases. E-nitiateBio is based in Hangzhou, China and was founded in 2020. It has raised $42.6 million.

Last price · $/share
—
Implied valuation
—
Total raised
$42.6M
Last round
—
Valuation — not yet established

No valuation for E-nitiateBio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($42.6M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of E-nitiateBio with a free account
  • ·The complete investor list: 11 names
  • ·Watch E-nitiateBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

E-nitiateBio funding history

No rounds on record

No funding rounds for E-nitiateBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How E-nitiateBio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For E-nitiateBio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about E-nitiateBio

How much has E-nitiateBio raised?
E-nitiateBio has raised $42.6M in total funding across its recorded rounds.